The assignee for this patent application is
Reporters obtained the following quote from the background information supplied by the inventors: "This invention relates polymeric medical devices, in particular, bioabsorbable stents or stent scaffoldings.
"This invention relates to radially expandable endoprostheses, that are adapted to be implanted in a bodily lumen. An 'endoprosthesis' corresponds to an artificial device that is placed inside the body. A 'lumen' refers to a cavity of a tubular organ such as a blood vessel. A stent is an example of such an endoprosthesis. Stents are generally cylindrically shaped devices that function to hold open and sometimes expand a segment of a blood vessel or other anatomical lumen such as urinary tracts and bile ducts. Stents are often used in the treatment of atherosclerotic stenosis in blood vessels. 'Stenosis' refers to a narrowing or constriction of a bodily passage or orifice. In such treatments, stents reinforce body vessels and prevent restenosis following angioplasty in the vascular system. 'Restenosis' refers to the reoccurrence of stenosis in a blood vessel or heart valve after it has been treated (as by balloon angioplasty, stenting, or valvuloplasty) with apparent success.
"Stents are typically composed of a scaffold or scaffolding that includes a pattern or network of interconnecting structural elements or struts, formed from wires, tubes, or sheets of material rolled into a cylindrical shape. This scaffolding gets its name because it physically holds open and, if desired, expands the wall of the passageway. Typically, stents are capable of being compressed or crimped onto a catheter so that they can be delivered to and deployed at a treatment site.
"Delivery includes inserting the stent through small lumens using a catheter and transporting it to the treatment site. Deployment includes expanding the stent to a larger diameter once it is at the desired location. Mechanical intervention with stents has reduced the rate of restenosis as compared to balloon angioplasty. Yet, restenosis remains a significant problem. When restenosis does occur in the stented segment, its treatment can be challenging, as clinical options are more limited than for those lesions that were treated solely with a balloon.
"Stents are used not only for mechanical intervention but also as vehicles for providing biological therapy. Biological therapy uses medicated stents to locally administer a therapeutic substance. Effective concentrations at the treated site require systemic drug administration which often produces adverse or even toxic side effects. Local delivery is a preferred treatment method because it administers smaller total medication levels than systemic methods, but concentrates the drug at a specific site.
"A medicated stent may be fabricated by coating the surface of either a metallic or polymeric scaffolding with a polymeric carrier that includes an active or bioactive agent or drug. Polymeric scaffolding may also serve as a carrier of an active agent or drug.
"The stent must be able to satisfy a number of mechanical requirements. The stent must be capable of withstanding the structural loads, namely radial compressive forces, imposed on the scaffold as it supports the walls of a vessel. Therefore, a stent must possess adequate radial strength. Radial strength, which is the ability of a stent to resist radial compressive forces, relates to a stent's radial yield strength and radial stiffness around a circumferential direction of the stent. A stent's 'radial yield strength' or 'radial strength' (for purposes of this application) may be understood as the compressive loading, which if exceeded, creates a yield stress condition resulting in the stent diameter not returning to its unloaded diameter, i.e., there is irrecoverable deformation of the stent. When the radial yield strength is exceeded the stent is expected to yield more severely and only a minimal force is required to cause major deformation. Radial strength is measured either by applying a compressive load to a stent between flat plates or by applying an inwardly-directed radial load to the stent.
"Once expanded, the stent must adequately maintain its size and shape throughout its service life despite the various forces that may come to bear on it, including the cyclic loading induced by the beating heart. For example, a radially directed force may tend to cause a stent to recoil inward. In addition, the stent must possess sufficient flexibility to allow for crimping, expansion, and cyclic loading.
"Some treatments with stents require its presence for only a limited period of time. Once treatment is complete, which may include structural tissue support and/or drug delivery, it may be desirable for the stent to be removed or disappear from the treatment location. One way of having a stent disappear may be by fabricating a stent in whole or in part from materials that erodes or disintegrate through exposure to conditions within the body. Stents fabricated from biodegradable, bioabsorbable, and/or bioerodible materials such as bioabsorbable polymers can be designed to completely erode only after the clinical need for them has ended.
"The development of a bioresorbable stent or scaffold could obviate the permanent metal implant in vessel, allow late expansive luminal and vessel remodeling, and leave only healed native vessel tissue after the full absorption of the scaffold. A fully bioabsorbable stent can reduce or eliminate the risk of potential long-term complications and of late thrombosis, facilitate non-invasive diagnostic MRI/CT imaging, allow restoration of normal vasomotion, provide the potential for plaque regression.
"However, there are several challenges making a bioabsorbable polymeric stent. These include making a stent with sufficient radial strength, stiffness, toughness or resistance to fracture, and a suitable degradation rate. Additionally, different kinds of treatment with stents have different requirements for the above properties. Another challenge is tailoring bioabsorbable stents to meet these varying requirements."
In addition to obtaining background information on this patent application, VerticalNews editors also obtained the inventor's summary information for this patent application: "Various embodiments of the present invention include a stent comprising a scaffolding made from a composite material including: a polymer including poly(L-lactide) (PLLA) as a matrix and poly-4-hyroxybutyrate (P4HB) dispersed throughout the PLLA; and bioceramic particles dispersed throughout the polymer, wherein the bioceramic particles are nanoparticles.
"Additional embodiments of the present invention include a method of making a stent comprising a scaffold including: combining PLLA, P4HB, bioceramic particles, and LLA to form a mixture; forming a tube from the mixture using an extruder; and forming a scaffold from the tube, wherein the scaffold comprises 5-15 wt % P4HB and 0.2-1 wt % LLA, and 1-5% bioceramic particles.
"Further embodiments of the present invention include a stent comprising a scaffolding made from a composite material including: a polymer including PLLA as a matrix and PLLA-b-PCL or PLLA-co-PCL dispersed throughout the PLLA; and bioceramic particles and LLA dispersed throughout the polymer.
"Other embodiments of the present invention include a method of making a stent comprising a scaffolding including: combining PLLA, PLLA-b-PCL or PLLA-co-PCL, bioceramic particles, and LLA to form a mixture; forming a tube from the mixture using an extruder; and forming a scaffold from the tube, wherein the scaffold comprises 5-15 wt % PLLA-b-PCL and 0.2-1 wt % LLA, and 1-5% wt % bioceramic particles.
"Additional embodiments of the present invention include a stent comprising a scaffolding made from a composite material including: an inner layer and an outer layer composed of PLLA containing 0 to 1 wt % LLA; a middle layer between the inner layer and the outer layer, the middle layer composed of P4HB with bioceramic particles dispersed throughout the P4HB, wherein the middle layer is 1 to 5 wt % bioceramic particles.
"Further embodiments of the present invention include a stent comprising a scaffolding made from a composite material including: an inner layer and an outer layer composed of PLLA; and a middle layer between the inner layer and the outer layer, the middle layer composed of PLLA-b-PCL or PLLA-co-PCL with bioceramic particles and LLA dispersed throughout the PLLA-b-PCL or PLLA-co-PCL, wherein the middle layer is 1 to 5 wt % bioceramic particles and 0.2-1 wt % LLA.
BRIEF DESCRIPTION OF THE DRAWINGS
"FIG. 1 depicts a stent.
"FIG. 2 depicts a portion of a strut of a scaffolding with a view directed at the side wall."
For more information, see this patent application: Wang, Yunbing. Bioabsorbable Scaffolds Made from Composites. Filed
Keywords for this news article include: Therapy, Treatment,
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC
Most Popular Stories
- 5 Notable Hispanic Technology Executives
- Top Hispanic Tech Companies Push for the Top
- Rand Paul Tops Presidential Straw Poll at Conservative PAC Conference
- Tesla's Alt-Energy Future Aims for Massive Lithium-Ion Battery Production
- New Chat App, Yik Yak, Causes Problems for Students
- China Urges Malaysia Flight Emergency Response
- Gas Prices May Jump from Calif. Emissions Law
- Visa, MasterCard Team Up to Focus on Payment Security
- Russia, Crimea Discuss Referendum
- Obama Meets with Ukraine Prime Minister Wednesday